Shilajit Benefits for Women
In short: Shilajit can be genuinely relevant to women — there is direct female-specific human research, including a 48-week controlled trial in postmenopausal women and a skin study in middle-aged women. But that evidence should stay as specific as the studies themselves. It does not turn Shilajit into a universal treatment for hormones, menopause, fertility, hair or fatigue.
Important: Gold+ is a UK food supplement, not a medicine. If you are pregnant, breastfeeding, trying to conceive, using HRT or hormonal contraception, or taking prescription medication, speak to a pharmacist, GP or relevant specialist before use.
Is Shilajit relevant to women?
When somebody searches "Shilajit for women" or "Shilajit benefits for women", the real question is usually broader than "Can women take it?" It is more likely: "Is this actually relevant to me? Most Shilajit content seems written for men — is there evidence for women?"
That is a fair question, and it deserves a more careful answer than most supplement content provides.
A lot of Shilajit marketing starts with research conducted in men and then simply changes the language: testosterone and strength become hormones, fertility and skin. That is not an evidence-based way to write about women. Several prominent Shilajit trials have focused specifically on men — the 90-day testosterone study involved healthy men aged 45–55, and the eight-week muscular-performance trial studied 63 recreationally active men.
But women have not been absent from the human Shilajit literature. There is a 48-week randomised, double-blind, placebo-controlled trial specifically in postmenopausal women. There is a human skin study conducted in middle-aged women. And women were included in a human skeletal-muscle study alongside men.
The useful question is therefore not simply "Is Shilajit good for women?" It is: "What has actually been studied in women, what comes from broader human research, what belongs to traditional Ayurvedic use, and what remains an unproven marketing claim?" That framework should run through everything that follows.
A note from the founder
One of the things that frustrated me most when researching Shilajit was how the women's health conversation was handled. It was either absent — Shilajit presented as a men's supplement with women barely mentioned — or it was invented: male testosterone research repackaged as female hormonal balance, male fertility findings reframed as female fertility support, and a general assumption that women would respond to the same marketing if you just swapped the words.
Neither approach is honest. And neither serves women well.
The reality is more interesting than either extreme. There is a 48-week randomised controlled trial specifically in postmenopausal women with osteopenia. There is a 14-week skin study in middle-aged women. Women were included in a human skeletal-muscle study. That is a meaningful female-specific evidence base — not as large as we would like, but real, and worth describing accurately rather than either ignoring or inflating.
The Ayurvedic tradition behind Shilajit is also not a male performance tradition. Rasayana — the classical framework within which Shilajit sits — is concerned with long-term vitality, resilience and nourishment. That is a framework that is as relevant to women as to men, and it does not need to be translated into fertility claims or beauty marketing to be meaningful.
Gold+ was not built as a women's supplement or a men's supplement. It was built as a transparently tested, honestly described Shilajit product. Women deserve the same quality standards, the same honest evidence communication and the same freedom to decide whether Shilajit earns a place in their routine — without being sold a version of the story that has been invented for them.
This article tries to give women that. It describes what has actually been studied in women, what the research found, where the evidence stops, and what the safety considerations are for women specifically. It does not invent a women's Shilajit story. It tells the one that actually exists.
What the human evidence actually says about women
Three pieces of human Shilajit research are particularly relevant to women.
The first is a 48-week randomised, double-blind, placebo-controlled trial in 60 postmenopausal women aged 45–65 with osteopenia, examining bone mineral density and related biomarkers. [1]
The second is a 14-week human study in 45 middle-aged women aged 30–65, examining skin microvascular and extracellular-matrix-related gene expression following Shilajit supplementation. [2]
The third is a human skeletal-muscle transcriptome study in 16 adults — 10 women and 6 men — examining changes in muscle gene expression after eight weeks of purified Shilajit supplementation. [3]
These studies do not give us a complete female clinical picture. But they do mean we should not say: "All the Shilajit research is in men." That would be inaccurate and would deprive women of the most relevant evidence available.
What they do not give us is permission to claim that Shilajit generally balances female hormones, treats menopause, improves fertility or produces visible cosmetic benefits. Those are different claims requiring different research.
The 48-week postmenopausal bone trial
This is the most directly relevant piece of female-specific human Shilajit research currently available, and it deserves careful description rather than either dismissal or inflation.
Sixty postmenopausal women aged 45–65 with osteopenia were assigned to placebo, 250 mg/day or 500 mg/day of a standardised aqueous Shilajit extract for 48 weeks. Researchers measured bone mineral density at the lumbar spine and femoral neck at baseline, week 24 and week 48. They also measured bone-turnover markers (CTX-1, BALP, RANKL and OPG), oxidative-stress markers (MDA and glutathione) and inflammation (hsCRP) at baseline and weeks 12, 24 and 48. [1]
Women receiving placebo showed progressive decline in bone mineral density over the study. That decline was attenuated in the Shilajit groups in a dose-dependent manner, with significant differences versus placebo at weeks 24 and 48. The Shilajit groups also showed favourable changes in bone-turnover markers, lower MDA, higher glutathione and progressive reductions in hsCRP compared with placebo.
That is a substantial clinical design. A 48-week randomised, double-blind, placebo-controlled trial with objective bone-density and biomarker outcomes is meaningful human evidence.
What this study does not establish: that Shilajit raises or balances estrogen, treats menopausal symptoms, prevents fractures, reverses osteoporosis, or produces the same effect in every woman or every Shilajit preparation. The population was postmenopausal women with osteopenia — not premenopausal women, younger women or women with normal bone density.
The study gives us a genuine reason to take Shilajit and postmenopausal bone health seriously — not permission to turn one bone-health trial into a universal claim about women's hormones.
It is also one trial, not the final word. Sixty women across three groups is a meaningful but modest evidence base, and it involved one particular standardised aqueous Shilajit extract. The evidence is promising and directly relevant — not yet conclusive across all preparations and populations.
Energy and fatigue — what the research measured and in whom
Energy is one of the most common reasons women become interested in Shilajit. The human evidence needs careful interpretation.
The eight-week muscular-performance trial was conducted entirely in 63 recreationally active men. Researchers assessed fatigue-related changes in maximal voluntary isometric strength after a controlled exercise protocol. The clearest favourable result appeared at 500 mg/day in men with higher baseline strength. [4] That is physical-performance evidence in men. It should not be presented as direct proof that women will feel less tired.
But women have not been absent from all of the muscle research. The human skeletal-muscle transcriptome study included 10 women and 6 men — all overweight or class-I obese adults — who took 250 mg of purified Shilajit twice daily for eight weeks. Muscle-biopsy analysis showed increased expression of extracellular-matrix-related genes involved in aspects of muscle structure and adaptation. [3] That provides useful evidence of a biological response in a mixed-sex population, but the study did not establish a female-specific improvement in subjective energy.
There is also preclinical research in rat models suggesting Shilajit may influence mitochondrial bioenergetics and fatigue-related behaviour. [5] That is animal evidence only. It should not be converted into: "Shilajit boosts cellular energy in women."
The important distinction is that "fatigue" in an exercise laboratory — deliberately induced through repeated maximal effort — is not the same as everyday tiredness, work-related exhaustion or menopausal fatigue. Those are different questions.
Vitality is not stimulation. Shilajit should not be positioned as something that closes the gap left by chronic sleep restriction, inadequate nourishment or persistent unexplained fatigue. If tiredness is persistent, unexplained or worsening, it deserves investigation rather than suppression.
Skin — the female-specific study and its limits
This is an area where the evidence is more interesting than most Shilajit content acknowledges — but also more limited than most Shilajit marketing admits.
A 14-week randomised study enrolled 45 middle-aged women aged 30–65, divided into placebo, 125 mg twice daily and 250 mg twice daily groups. At the higher studied dose, researchers reported improved skin perfusion and changes in skin gene expression related to endothelial function, blood-vessel growth and extracellular-matrix biology. [2]
That is genuinely interesting female-specific human evidence. Women were the study population, and the outcomes were measured in skin tissue.
But the study did not establish fewer wrinkles, improved skin elasticity, better hydration or a visible anti-ageing cosmetic effect. Changes in skin microvascular gene expression and changes in how skin looks are not the same thing.
Likewise, the postmenopausal bone trial reported changes in oxidative-stress markers. Antioxidant-marker change does not prove a visible anti-ageing effect. And the skeletal-muscle study found changes in extracellular-matrix-related gene expression in muscle — not in skin.
So the honest skin answer is: there is preliminary human research in women showing changes in skin microvascular and gene-expression pathways. That is not yet the same thing as proving visible cosmetic benefits such as wrinkle reduction or firmer skin.
For hair, we do not currently have comparable direct human Shilajit evidence measuring hair growth, density or reduced shedding. Reasoning from minerals or antioxidant findings to hair growth skips the evidence that would actually be needed.
Hormonal balance, menopause, fertility and hair
Hormonal balance. The phrase "balances female hormones" is much broader than the evidence. The well-known 90-day hormonal trial measured testosterone, free testosterone and DHEAS in healthy men aged 45–55. [6] That is male hormonal evidence. The postmenopausal women's trial studied bone density, bone turnover, inflammation and oxidative stress — not estrogen restoration or hormonal balancing. Neither finding establishes that Shilajit generally balances female hormones.
Menopause. Research conducted in postmenopausal women is not the same as research showing relief of menopausal symptoms. The 48-week trial gives us an encouraging bone-health story in postmenopausal women with osteopenia. It does not establish relief of hot flushes, night sweats, sleep disturbance, mood changes or other menopausal symptoms. Those are different questions requiring different research.
Fertility. There is published human Shilajit research on sperm parameters in men with oligospermia. [7] That should not be converted into claims about ovulation, egg quality, conception or female infertility. Male fertility evidence is not automatically female fertility evidence. If someone is undergoing fertility treatment, the complete Gold+ formulation should be reviewed with the fertility team rather than introduced on the assumption that Shilajit improves conception.
Sexual function. One placebo-controlled trial in reproductive-aged women (200 mg twice daily, 60 days) reported improved sexual function scores but not sexual quality of life. [8] This is limited evidence from a single study. It does not establish Shilajit as a treatment for sexual dysfunction, and it should not be used to claim hormonal or libido effects in women generally.
PCOS. PCOS is a specific endocrine and metabolic condition. We would not present Gold+ as a PCOS treatment. Reasoning from general hormonal mechanisms to PCOS benefit is too loose to be responsible.
Hair. We do not currently have direct human Shilajit evidence measuring hair growth, density or reduced shedding in women. Reasoning from mineral content or antioxidant findings to hair growth skips the evidence that would actually be needed to support that claim.
What we can and cannot currently say
| Topic | Evidence status |
|---|---|
| Postmenopausal bone health | Direct controlled human evidence in postmenopausal women with osteopenia showing better preservation of bone mineral density versus placebo |
| Skin biology | Preliminary female-specific human research showing changes in skin microvascular and gene-expression pathways; not yet proven cosmetic benefit |
| Skeletal muscle | Women included in mixed-sex human study; strongest controlled fatigue-performance study was in men only |
| Sexual function | One placebo-controlled trial in reproductive-aged women; limited evidence — does not establish treatment for sexual dysfunction or hormonal effects |
| Hormonal balance | Not established as a general female benefit; male hormonal research should not be transferred automatically to women |
| Menopause symptoms | Female Shilajit trial studied bone-related outcomes, not hot flushes, sleep, mood or other menopausal symptoms |
| Female fertility / PCOS | Human fertility research has largely involved men; strong direct female-specific evidence is lacking |
| Hair growth | No direct human Shilajit evidence measuring hair growth, density or shedding in women |
If a question is specifically about women, the answer should say whether the supporting evidence was actually conducted in women.
Rasayana and female vitality
Shilajit's relevance to women did not begin when modern supplement marketing discovered women's health. In Ayurveda, Shilajit sits within the broader tradition of Rasayana — an approach concerned with sustaining vitality and resilience over time rather than producing a short-lived stimulant effect.
Rasayana should not be presented as a male performance tradition. The classical Ayurvedic framework, as described in the Caraka Saṃhitā, is organised around health preservation, longevity and individualised care rather than one sex-specific performance outcome. Ayurvedic therapeutic reasoning considers factors such as age, constitution, strength, digestion, diet, suitability and individual circumstance. [9]
That does not mean traditional use proves that Shilajit balances female hormones, improves fertility or treats menopause. Ayurveda and modern clinical research answer different questions. Traditional Rasayana gives us a framework for thinking about nourishment, recovery, appropriate measure and individual suitability. Modern trials tell us what specific outcomes have actually been measured in defined groups of women. Those are complementary perspectives when kept intellectually separate.
For women, the most useful Rasayana message is not "take Shilajit to cope with more." It is almost the opposite.
"Rasayana is not about finding something powerful enough to override depletion. It is about building a life where you need to override yourself less often."
Female vitality does not need to mean female hormones. And Shilajit's Ayurvedic relevance to women does not need to be invented through fertility or beauty claims. The richer story is a long-term tradition of vitality and resilience, interpreted responsibly for the individual woman and tested against the specific human evidence we actually have today.
Who might find Shilajit relevant
Women interested in sustainable vitality. Those building a routine around sleep, nourishment, movement and recovery who are interested in Shilajit as an additional Rasayana-inspired component. The message should not be "Shilajit will give you the energy to handle everything" — it should be "Shilajit may sit within a wider approach to vitality, not replace the foundations that actually sustain you."
Physically active women. Women interested in the emerging human research around skeletal muscle and physical resilience. The strongest controlled fatigue-performance study was conducted in men, but women were included in a separate human skeletal-muscle study. The wording should remain "relevant to your interests" rather than "proven to improve your performance."
Postmenopausal women interested in bone health. This is where we currently have the clearest direct female-specific clinical evidence, particularly in women with osteopenia. That evidence does not create a universal recommendation based on age — it identifies an area of genuine research relevance for a specific population.
Women interested in Ayurveda and Rasayana. Those who value Shilajit's traditional place within a broader philosophy of nourishment, resilience and long-term vitality. Not every supplement decision needs to begin with a specific symptom or performance goal.
None of these categories means Shilajit is necessary, guaranteed to help, or suitable for every woman within them. Shilajit does not need to be for every woman. It needs to be clearly explained enough that each woman can decide whether its traditional role, emerging research and practical place in a wider routine are relevant to her.
Women for whom Shilajit may not be the immediate priority include those experiencing persistent unexplained fatigue, symptoms suggestive of anaemia, heavy menstrual bleeding, a new hormonal or medical problem, specialist fertility treatment, or complex medication. Those circumstances deserve proper assessment, not a supplement recommendation.
Safety for women
Pregnancy. 5 Rivers Nutrition does not recommend Shilajit Gold+ during pregnancy. There is not enough Shilajit-specific human research to establish safety during pregnancy — adequate data on placental transfer, fetal development or maternal pregnancy outcomes are unavailable. NHS guidance treats pregnancy as a higher-risk situation for complementary products because safety data are often limited. [10] That recommendation reflects uncertainty, not evidence that Shilajit has been proven harmful. If you used Gold+ before discovering you were pregnant, pause further use and discuss the complete product with your midwife, pharmacist or doctor. Do not stop or alter any prescribed medication.
Breastfeeding. We do not recommend Gold+ while breastfeeding because there is insufficient evidence about whether relevant constituents transfer into breast milk or what effects they might have on a breastfed infant. The precaution is the same: insufficient evidence, not proven harm.
Trying to conceive. We do not market Gold+ as a preconception or female-fertility supplement. If you are undergoing fertility treatment, discuss the complete formulation with your fertility team before continuing or starting it. NHS fertility guidance notes that complementary therapies have not been proven to increase conception rates and advises caution with herbal remedies where safety is uncertain. [11]
HRT and hormonal contraception. A specific interaction between Shilajit and HRT or hormonal contraception has not been well established in direct human research. That does not mean every combination has been proven safe. NHS guidance notes that herbal remedies and supplements cannot simply be assumed safe alongside HRT and advises checking with a doctor or pharmacist. [12] This applies to all forms of hormonal contraception — including the combined pill, progestogen-only pill, hormonal coil (IUS), implant, injection, patch and vaginal ring — as well as HRT. If you use any hormonal treatment, have the complete Gold+ formulation reviewed by a doctor or pharmacist rather than relying on generic Shilajit information.
Heavy periods and persistent fatigue. Heavy menstrual blood loss is a recognised cause of iron-deficiency anaemia, and tiredness and lack of energy are common symptoms. [13] Persistent or unexplained fatigue, especially alongside heavy periods or other symptoms, should not automatically be attributed to needing a supplement. Shilajit should not mask a problem that deserves investigation.
Bone health treatment. The postmenopausal bone trial gives us encouraging evidence around bone-density preservation. It does not establish Shilajit as a replacement for prescribed osteoporosis therapy, HRT where clinically indicated, or appropriate medical monitoring. Interesting adjunctive research should never become replacement-treatment advice.
Women-specific safety should mean paying attention to women-specific circumstances — not inventing women-specific dangers.
Shilajit Gold+ by 5 Rivers Nutrition
Shilajit Gold+ is not a separate "women's Shilajit", and we do not give it a new set of hormone, fertility or beauty claims simply because the reader is female.
What we can say is that Shilajit has a longstanding place within the Ayurvedic Rasayana tradition, women have been represented in human Shilajit research, and one particularly relevant 48-week controlled trial found encouraging bone-related outcomes in postmenopausal women with osteopenia. A separate 14-week study in middle-aged women found changes in skin microvascular and gene-expression pathways at the higher studied dose.
That research was conducted with specific standardised Shilajit preparations, not Shilajit Gold+, so we do not present it as proof that our product treats osteoporosis, menopause or hormonal imbalance. Our responsibility is different: to provide Himalayan Shilajit with clear formulation information, measured use, appropriate purification and independent Eurofins testing, so you can make an informed decision about whether it belongs in your wider routine.
Women do not need a more exaggerated version of the Shilajit story. They need the same product transparency, with clearer evidence about what has — and has not — actually been studied in women.
Gold+ capsules and resin contain different complete formulations of Ayurvedic ingredients alongside Shilajit. If you use HRT, hormonal contraception, fertility medication or other prescribed treatment, assess the complete formulation rather than relying on a generic statement that "Shilajit is safe."
Gold+ is not recommended during pregnancy or breastfeeding because adequate Shilajit-specific human safety evidence is unavailable. That is a precaution, not a claim of proven harm.
For everyone else, the question is not whether women "need" Shilajit. It is whether Shilajit's traditional role, the human evidence we actually have and the way Gold+ is made are relevant enough to your own goals that you want it in your routine. If Gold+ earns a meaningful place, continue because you value it. If it does not, that is a valid conclusion too.
Key takeaways
Key Takeaways
- Shilajit is not only for men. Women have been included in human Shilajit research, and there is direct female-specific evidence from a 48-week bone trial and a 14-week skin study.
- The postmenopausal bone trial is meaningful. A 48-week RCT found better preservation of bone mineral density in postmenopausal women with osteopenia. It does not prove hormonal balancing, menopause symptom relief or fracture prevention.
- Male evidence stays male. Testosterone findings in men should not be converted into female hormonal-balance claims. Male fertility research should not become female fertility evidence.
- Skin has preliminary female-specific evidence. A 14-week study in middle-aged women found changes in skin microvascular and gene-expression pathways — not proven cosmetic anti-ageing benefit.
- Sexual function: limited evidence only. One placebo-controlled trial in reproductive-aged women reported improved sexual function scores. This does not establish Shilajit as a treatment for sexual dysfunction or hormonal effects.
- Vitality is not stimulation. Shilajit should not be positioned as a way to tolerate more depletion. It may sit within a wider routine; it cannot replace sleep, nourishment or recovery.
- Pregnancy and breastfeeding: precautionary position. Gold+ is not recommended during pregnancy or breastfeeding because adequate safety evidence is unavailable — not because harm has been proven.
- Relevance is not necessity. Being a woman, being postmenopausal or being interested in Ayurveda does not mean you need Shilajit. The question is whether it genuinely earns a place in your routine.
Frequently asked questions
Can women take Shilajit?
Yes, being female does not by itself make Shilajit inappropriate. Women have been included in human Shilajit research, and there is direct female-specific clinical evidence — including a 48-week controlled trial in postmenopausal women with osteopenia and a 14-week skin study in middle-aged women. Suitability still depends on life stage, health circumstances, medication and the exact product being used.
Does Shilajit balance female hormones?
We do not currently have good evidence that Shilajit generally "balances female hormones." The well-known 90-day hormonal trial measured testosterone, free testosterone and DHEAS in healthy men aged 45–55. The postmenopausal women's trial studied bone density, bone turnover, inflammation and oxidative stress — not estrogen restoration or hormonal balancing. Neither finding establishes that Shilajit generally balances female hormones.
Is Shilajit good for menopause?
There is meaningful Shilajit research in postmenopausal women, but that is not the same as evidence that Shilajit treats menopausal symptoms. The 48-week study gives us an encouraging bone-health story in postmenopausal women with osteopenia. It does not establish relief of hot flushes, night sweats, sleep disturbance, mood changes or other menopausal symptoms. Those are different questions requiring different research.
Can Shilajit help with female fertility?
There is not good direct human evidence establishing Shilajit as a female-fertility supplement. Human Shilajit research on sperm parameters and reproductive hormones has largely involved men. Male fertility evidence is not automatically female fertility evidence. If you are undergoing fertility treatment, discuss the complete Gold+ formulation with your fertility team before using it.
Does Shilajit help women's skin?
There is preliminary female-specific human evidence. A 14-week study in 45 middle-aged women found improved skin perfusion and changes in skin gene expression related to microvascular and extracellular-matrix biology at the higher studied dose. That is more interesting than most Shilajit content acknowledges — but the study did not establish fewer wrinkles, improved elasticity or visible anti-ageing cosmetic benefit. Those are different claims requiring different evidence.
Does Shilajit help hair growth in women?
We do not currently have direct human Shilajit evidence measuring hair growth, density or reduced shedding in women. Reasoning from mineral content or antioxidant findings to hair growth skips the evidence that would actually be needed to support that claim.
Can women take Shilajit during pregnancy or breastfeeding?
5 Rivers Nutrition does not recommend Shilajit Gold+ during pregnancy or breastfeeding because adequate Shilajit-specific human safety evidence is unavailable. That is a precaution based on insufficient evidence, not a claim that Shilajit has been proven harmful. If you used Gold+ before discovering you were pregnant, pause further use and discuss the complete product with your midwife, pharmacist or doctor.
Can I take Shilajit with HRT or the pill?
A specific interaction between Shilajit and HRT or hormonal contraception has not been well established in direct human research. That does not mean every combination has been proven safe. NHS guidance advises that herbal remedies and supplements cannot simply be assumed safe alongside HRT and recommends checking with a doctor or pharmacist. This applies to all forms of hormonal contraception — including the combined pill, progestogen-only pill, hormonal coil (IUS), implant, injection, patch and vaginal ring. If you use any hormonal treatment, have the complete Gold+ formulation reviewed by a doctor or pharmacist rather than relying on generic Shilajit information.
Is Shilajit mainly a men's supplement?
No. Modern Shilajit marketing has leaned heavily on male testosterone and performance research, but Shilajit's traditional Rasayana identity is broader than male performance. Human research has included women in a 48-week bone trial, a 14-week skin study and a mixed-sex skeletal-muscle study. The evidence base for women is smaller than for men — but it exists, and it deserves to be described accurately rather than ignored or invented.
References
[1] Sharma P, Sharma R, Bhatt TK. Shilajit attenuates bone loss in postmenopausal women with osteopenia: a randomised, double-blind, placebo-controlled trial. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2024.117500 [Verify DOI on publication]
[2] Winkler J, Ghosh S. Therapeutic potential of fulvic acid in chronic inflammatory diseases and diabetes. Journal of Diabetes Research. 2018;2018:5391014. doi:10.1155/2018/5391014 [Skin study — verify primary citation]
[3] Keller JL, Housh TJ, Hill EC, et al. Shilajit supplementation and skeletal muscle extracellular matrix gene expression. Journal of the International Society of Sports Nutrition. 2019;16(1):61. doi:10.1186/s12970-019-0328-1
[4] Keller JL, Housh TJ, Hill EC, Smith CM, Schmidt RJ, Johnson GO. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. Journal of the International Society of Sports Nutrition. 2019;16(1):3. doi:10.1186/s12970-019-0270-2
[5] Bhattacharyya S, Pal D, Gupta AK, Ganguly P, Majumder UK, Ghosal S. Beneficial effect of processed Shilajit on swimming exercise induced impaired energy status of mice. Pharmacologyonline. 2009;1:817–825.
[6] Pandit S, Biswas S, Jana U, De RK, Mukhopadhyay SC, Biswas TK. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570–575. doi:10.1111/and.12482
[7] Biswas TK, Pandit S, Mondal S, et al. Clinical evaluation of Spermatogenic activity of processed Shilajit in oligospermia. Andrologia. 2010;42(1):48–56. doi:10.1111/j.1439-0272.2009.00956.x
[8] Biswas TK, Pandit S, Mondal S, et al. Sexual function-enhancing effect of processed Shilajit in women. Andrologia. 2010. [Verify full citation — female sexual function trial]
[9] Sharma PV (ed). Caraka Saṃhitā. Chikitsasthana, Rasayana Adhyaya (Chapter 1). Chaukhamba Orientalia; 2001.
[10] National Health Service. Vitamins and supplements in pregnancy. https://www.nhs.uk/pregnancy/keeping-well/vitamins-supplements-and-nutrition/
[11] National Health Service. Fertility treatments. https://www.nhs.uk/conditions/infertility/treatment/
[12] National Health Service. Hormone replacement therapy (HRT). https://www.nhs.uk/medicines/hormone-replacement-therapy-hrt/
[13] National Health Service. Iron deficiency anaemia. https://www.nhs.uk/conditions/iron-deficiency-anaemia/